-
Mashup Score: 0Faulty Tricuspid Valve Linked to Less Success for Mitral Valve Therapy - 11 month(s) ago
Registry analyses look at which patients may be candidates for transcatheter tricuspid therapies
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Point-of-Care App | SCAI - 11 month(s) ago
Your New Essential Resource SCAI’s free point-of-care app for your tablet and phone mobilizes the latest clinical guidelines and best practices in interventional cardiology so that you can access their findings and recommendations wherever and whenever you need them to improve your patient’s outcomes. Evidence-based content includes: Clinical guidelines Risk calculators Decision-support…
Source: scai.orgCategories: Cardiologists, Latest HeadlinesTweet-
RT @MyJSCAI: Have you heard? You can access #JSCAI articles through the new @SCAI point-of-care app. #SCAI2023 📱https://t.co/rPuQ2tVZly h…
-
-
Mashup Score: 0Novel percutaneous VAD for high risk-PCI feasible, safe in small study - 11 month(s) ago
Use of a novel miniaturized, expandable percutaneous ventricular assist device was shown to be feasible and potentially safe in a small study of six high-risk patients undergoing PCI, a speaker reported.The first-in-human data of a novel percutaneous VAD system (Supira Medical) for high-risk PCI were presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: "The smaller you go, the less support you get ... That’s where this Supira device comes in. It’s a single percutaneous assist device ... it’s a device that can be used for both high-risk PCI and cardiogenic shock” @SCAI #SCAI2023 #cardiotwitter https://t.co/7bfoqqAHgv
-
-
Mashup Score: 0Registry to better guide CLTI care; 1 in 6 patients die within first year of diagnosis - 11 month(s) ago
Among 1.13 million patients with chronic limb-threatening ischemia and long-term follow-up, approximately one in six died within their first year of diagnosis, a rate that increased to half by 5 years, a speaker reported.Insights from the CLIPPER database, designed to inform the quality of care for patients with CLTI, were presented at the Society for Cardiovascular Angiography and Interventions
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: "Unlike other common and morbid [CVDs], like heart attack, stroke and heart failure, no quality metrics have been developed to measure processes of care for chronic limb-threatening ischemia" @PennMDForum @SCAI #SCAI2023 #cardiotwitter https://t.co/eCle3E1bfv
-
-
Mashup Score: 0Conference News | tctmd.com - 11 month(s) ago
Hub page
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Stay up to date with the latest news from major cardiovascular conferences. This week, TCTMD is covering ESC #HeartFailure2023, #EAS2023, #SCAI2023, and #ESOC2023! Our journalists are all over the world, reporting on TRACER-HF, ARCADIA, BIOMAG-1, and more: https://t.co/gucTMMS2hP
-
-
Mashup Score: 1Registry to better guide CLTI care; 1 in 6 patients die within first year of diagnosis - 11 month(s) ago
Among 1.13 million patients with chronic limb-threatening ischemia and long-term follow-up, approximately one in six died within their first year of diagnosis, a rate that increased to half by 5 years, a speaker reported.Insights from the CLIPPER database, designed to inform the quality of care for patients with CLTI, were presented at the Society for Cardiovascular Angiography and Interventions
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: "Unlike other common and morbid [CVDs], like heart attack, stroke and heart failure, no quality metrics have been developed to measure processes of care for chronic limb-threatening ischemia" @PennMDForum @SCAI #SCAI2023 #cardiotwitter https://t.co/eCle3E1bfv
-
-
Mashup Score: 0Novel percutaneous VAD for high risk-PCI feasible, safe in small study - 11 month(s) ago
Use of a novel miniaturized, expandable percutaneous ventricular assist device was shown to be feasible and potentially safe in a small study of six high-risk patients undergoing PCI, a speaker reported.The first-in-human data of a novel percutaneous VAD system (Supira Medical) for high-risk PCI were presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: "The smaller you go, the less support you get ... That’s where this Supira device comes in. It’s a single percutaneous assist device ... it’s a device that can be used for both high-risk PCI and cardiogenic shock” @SCAI #SCAI2023 #cardiotwitter https://t.co/7bfoqqAHgv
-
-
Mashup Score: 1Bioprosthetic Valve Failure: Insights From VARC-3 - 11 month(s) ago
Janarthanan Sathananthan, MBChB, FSCAI
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
From CLD's Newsroom @SCAI Hear from @J_Sathananthan, a SCAI “30 in Their 30’s” early career award winner, on “Bioprosthetic Valve Failure: Insights From VARC-3” https://t.co/9UvtTdMvsI #cardiotwitter #SCAI2023
-
-
Mashup Score: 0CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI - 11 month(s) ago
The cohort could help generate evidence for quality measures indicative of better outcomes in various subgroups.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
Earlier revasc and better wound care could factor into a quality metric framework. #CLIfighters #SCAI2023 @ACFanaroff https://t.co/2rNa5YodKv
-
-
Mashup Score: 0Novel percutaneous VAD for high risk-PCI feasible, safe in small study - 11 month(s) ago
Use of a novel miniaturized, expandable percutaneous ventricular assist device was shown to be feasible and potentially safe in a small study of six high-risk patients undergoing PCI, a speaker reported.The first-in-human data of a novel percutaneous VAD system (Supira Medical) for high-risk PCI were presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Use of a novel miniaturized, expandable percutaneous ventricular assist device was shown to be feasible and potentially safe in a small study of six high-risk patients undergoing PCI @ucdavis @SCAI #SCAI2023 #cardiotwitter https://t.co/7bfoqqBf63
-
Tricuspid regurgitation at baseline was linked to poorer outcomes after percutaneous mitral valve repair and didn't improve for most patients afterward, two registry studies showed. #TR #SCAI #SCAI2023 https://t.co/V3nspaMHON